2016
DOI: 10.1016/j.etap.2015.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptome profiling and pathway analysis of hepatotoxicity induced by tris (2-ethylhexyl) trimellitate (TOTM) in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 74 publications
0
7
0
Order By: Relevance
“…In rats, TOTM induced hepatic vascular congestion, lipid globules in hepatocytes, with significantly decreased hepatocyte mitochondrial membrane antigen immune reaction indicating liver toxicity [ 28 ]. Intravenous injection of TOTM in mice induced upregulation of 694 genes and downregulation of 974 genes in liver [ 29 ]. Further analyses of 11 genes revealed that the functions of cell cycle pathway, oxidative process and lipid metabolism were affected during hepatotoxic effects of TOTM in mice.…”
Section: Introductionmentioning
confidence: 99%
“…In rats, TOTM induced hepatic vascular congestion, lipid globules in hepatocytes, with significantly decreased hepatocyte mitochondrial membrane antigen immune reaction indicating liver toxicity [ 28 ]. Intravenous injection of TOTM in mice induced upregulation of 694 genes and downregulation of 974 genes in liver [ 29 ]. Further analyses of 11 genes revealed that the functions of cell cycle pathway, oxidative process and lipid metabolism were affected during hepatotoxic effects of TOTM in mice.…”
Section: Introductionmentioning
confidence: 99%
“…Intravenous administration of DINCH to rats did not affect their behavior (David et al, 2015). Importantly, lack of data on neurotoxicity of alternative plasticizers does not necessarily mean that these compounds are neurodevelopmentally safe and can be used safely, especially as several have been linked with adverse effects in other toxicity endpoints (Ghisari and Bonefeld-Jorgensen, 2009;Takeshita et al, 2011;Chen et al, 2016;A. Engel et al, 2018;Moche et al, 2021).…”
Section: Tablementioning
confidence: 99%
“…For example, there is a lack of information regarding the toxicity of and the fate of the metabolites of alternative plasticizers (which is particularly important given that many of the negative health effects associated with DEHP are known to stem from its metabolites rather than the parent compound), including toxicological endpoints such as carcinogenicity and endocrine disruption [40]. As new concerns have been raised about some of these DEHP replacements, such as DINP [11,41,42,43,44,45], it is increasingly important to produce truly green replacement plasticizers, with the factors advancing hazard reduction playing a bigger role in plasticizer development. Furthermore, with hundreds of commercial plasticizers available today for numerous applications, it is important to ensure that these and new plasticizers are evaluated and designed systematically and thoroughly, to avoid the “regrettable substitution” of one problematic compound with another [35].…”
Section: Historical Perspectivementioning
confidence: 99%